Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Foamix Pharmaceuticals Ltd patents


Recent patent applications related to Foamix Pharmaceuticals Ltd. Foamix Pharmaceuticals Ltd is listed as an Agent/Assignee. Note: Foamix Pharmaceuticals Ltd may have other listings under different names/spellings. We're not affiliated with Foamix Pharmaceuticals Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Foamix Pharmaceuticals Ltd-related inventors


Compositions and methods for treating rosacea and acne

Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.. ... Foamix Pharmaceuticals Ltd

Wax foamable vehicle and pharmaceutical compositions thereof

Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided. In some embodiments, the wax is a liquid wax. ... Foamix Pharmaceuticals Ltd

Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof

The present invention teaches a foamable pharmaceutical and cosmetic compositions comprising an aprotic polar solvent; foam compositions and uses thereof.. . ... Foamix Pharmaceuticals Ltd

Foamix Pharmaceuticals Ltd.

. . ... Foamix Pharmaceuticals Ltd

Foamable vehicle and pharmaceutical compositions thereof

A hygroscopic pharmaceutical composition includes at least one hygroscopic substance at a concentration sufficient to provide an aw value of at least 0.9 and an antiinfective agent. A foamble pharmaceutical carrier includes about 50% to about 98% of a polar solvent selected from the group consisting of a polyol and peg; 0% to about 48% of a secondary polar solvent; about 0.2% to about 5% by weight of a surface-active agent; about 0.01% to about 5% by weight of at least one polymeric agent; and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.. ... Foamix Pharmaceuticals Ltd

Topical tetracycline compositions

A topical therapeutic hydrophobic breakable composition includes a carrier comprising (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agents selected from the group consisting of a fatty alcohol, a fatty acid and a wax; and (c) a tetracycline antibiotic, characterized in that at least part of the tetracycline antibiotic is suspended in the composition; the viscosity of the composition is at least about 30% higher than the viscosity of the carrier without the tetracycline antibiotic; and is higher than the viscosity of the hydrophobic oil and the tetracycline antibiotic without the viscosity modifying agents. The tetracycline is chemically stable in the composition for at least six months; wherein more than about 90% of the tetracycline has not broken down. ... Foamix Pharmaceuticals Ltd

Body cavity foams

The invention relates to an alcohol-free cosmetic or therapeutic foam carrier comprising water, a hydrophobic organic carrier, a foam adjuvant agent, a surface-active agent and a gelling agent. The cosmetic or therapeutic foam carrier does not contain aliphatic alcohols, making it non-irritating and non-drying. ... Foamix Pharmaceuticals Ltd

Foam prepared from nanoemulsions and uses

The present invention provides a foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa of the nose, mouth, eye, ear, respiratory system, vagina or rectum, and methods of using such a composition to treat, alleviate, or prevent a disorder of the skin, body cavity, or mucosal surface. The foamable oil in water nano emulsion composition includes: (a) a nano oil globule system, comprising substantially of sub-micron oil globules; (b) about 0.1% to about 5% by weight of at least one stabilizing agent selected from (i) a non-ionic surfactant, (ii) an ionic surfactant, or (iii) a polymeric agent; and (c) a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition, water and optional ingredients. ... Foamix Pharmaceuticals Ltd

Foamable compositions, breakable foams and their uses

A substantially surface active agent-free foamable composition which includes short-chain alcohol, water, polymer, fatty alcohol or fatty acid or a combination of fatty alcohol and fatty acid and propellant. A substantially surface active agent-free foamable composition which includes, water, polymer, fatty alcohol or fatty acid and propellant. ... Foamix Pharmaceuticals Ltd

Oil foamable carriers and formulations

A waterless foamable pharmaceutical composition suitable for external administration is disclosed. The composition includes a foamable carrier least one liquefied or compressed gas propellant. ... Foamix Pharmaceuticals Ltd

Foamix Pharmaceuticals Ltd.

. . ... Foamix Pharmaceuticals Ltd

Foam containing benzoyl peroxide

The present invention relates to foamable compositions for treating acne comprising benzoyl peroxide; to a therapeutic kit comprising such compositions; and to a method of treating acne using such compositions.. . ... Foamix Pharmaceuticals Ltd

Apparatus and method for releasing a unit dose of content from a container

An apparatus for delivering a predetermined quantity of content from a pressurized container includes a dispensing assembly which sits on the container and connects with an upper portion of a valve stem of the valve assembly, wherein the dispensing assembly includes a) an actuator cap having a discharge passage, which is open or obstructed and wherein the actuator cap acts as a metering chamber in combination with b) an adaptor which fits inside the cap and also snuggly engages the valve stem. The cap fits snuggly over the adjuster to define a metering chamber which depending on its position can close off the metered chamber or open it to the dispensing conduit nozzle. ... Foamix Pharmaceuticals Ltd

Penetrating pharmaceutical foam

The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.. ... Foamix Pharmaceuticals Ltd

01/19/17 / #20170014517

Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders

The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active agents for the treatment of human skin, especially in the treatment of acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, p. Acne bacteria associated disorders, and other superficial infections, including skin infections.. ... Foamix Pharmaceuticals Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Foamix Pharmaceuticals Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Foamix Pharmaceuticals Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###